| Financial Year |
March 31 2023 |
| Monetary Funds |
172,135,413.56 |
| Held-for-trading Financial Assets |
17,862,800.00 |
| Notes Receivable |
69,131,460.62 |
| Accounts Receivable |
276,709,435.76 |
| Advances to Suppliers |
11,598,651.43 |
| Other Receivables |
5,014,076.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
249,994,423.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,051,780.83 |
| Other Current Assets |
11,770,874.46 |
| Total Current Assets |
894,842,327.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
132,749,146.34 |
| Investment Properties |
603,464,392.34 |
| Fixed Assetes |
425,915,713.77 |
| Under-construction Projects |
20,274,550.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,668,983.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,156,335.06 |
| Deferred Income Tax Assets |
30,476,657.59 |
| Other Non-Current Assets |
59,791,762.77 |
| Sub-Total of Non-Current Assets |
1,345,063,783.56 |
| Total Assets |
2,239,906,110.63 |
| Short-Term Loans |
17,567,018.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
114,929,323.23 |
| Accounts Payable |
114,816,805.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,647,679.79 |
| Taxes Payable |
8,377,671.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
25,796,000.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,063,451.00 |
| Other Current Liabilities |
6,423,462.24 |
| Sub-Total of Current Liabilities |
318,685,911.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,422,222.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,467,238.98 |
| Total Liabilities |
350,153,150.25 |
| Paid-In Capital(Or Share Stock) |
603,000,000.00 |
| Capital Surplus |
239,924,014.06 |
| Surplus Reserve |
195,250,328.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
852,955,013.33 |
| Minority Stockholder's Interest |
-1,500,687.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,891,253,648.11 |
| Owner's Equity（Stockholder's Equity） |
1,889,752,960.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,239,906,110.63 |
